Michael Gladstone - 17 Jun 2022 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Reporting relationship: Director
Issuer ticker: DAWN
Reported as of: 17 Jun 2022
Net transaction value: +$11,500,005
SEC form: 4
Accepted by SEC: 22 Jun 2022, 16:47:17 UTC
Prior SEC filing: 26 May 2021
Next SEC filing: 23 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Ommer Chohan, Attorney-in-Fact

Key filing fact

Michael Gladstone filed Form 4 for Day One Biopharmaceuticals, Inc. (DAWN) on 22 Jun 2022.

Key facts

This page summarizes Michael Gladstone's Form 4 filing for Day One Biopharmaceuticals, Inc. (DAWN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2022, 16:47.

Change

Previous filing in this sequence was filed on 26 May 2021.
Current net transaction value: +$11,500,005.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DAWN transaction

Common Stock

Purchase

Transaction value: $11,500,005
Shares: +766,667
Change %
Price: $15.00
Shares after: 766,667
Date: 17 Jun 2022
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, LP ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. The Reporting Person is a member of AVAO II LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF II, except to the extent of his pecuniary interest therein, if any.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney